Curet Myriam - 20 Mar 2025 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role: Director
Signature: /s/ Bryan Phillips, Attorney-in-Fact for Myriam J. Curet, M.D.
Issuer symbol: INSP
Transactions as of: 20 Mar 2025
Transactions value $: $188
Form type: 4
Filing time: 24 Nov 2025, 20:40:17 UTC
Previous filing: 03 Mar 2025
Next filing: 28 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Curet Myriam	Director	C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY	/s/ Bryan Phillips, Attorney-in-Fact for Myriam J. Curet, M.D.	24 Nov 2025	0001632901

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INSP	Common Stock	Purchase	$655	+4	+0.12%	$163.84	3.37K	20 Mar 2025	Direct	F1
transaction	INSP	Common Stock	Purchase	$148	+1	+0.03%	$148.26	3.37K	07 Apr 2025	Direct	F1
transaction	INSP	Common Stock	Sale	-$306	-2	-0.06%	$153.22	3.37K	08 May 2025	Direct	F1, F2
transaction	INSP	Common Stock	Sale	-$309	-4	-0.12%	$77.28	3.37K	08 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.
F2	The Reporting Person's sale of common stock on May 8, 2025 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1 share at a price per share of $153.2237, with the Reporting Person's purchase of 1 share of common stock at a price per share of $148.262 on April 7, 2025. Dr. Curet paid to the Issuer $4.97, representing the full amount of the profit realized in connection with the short-swing transaction.

Content

These transactions occurred inadvertently through holdings in a pooled investment vehicle that did not filter out the Issuer's securities.

The Reporting Person's sale of common stock on May 8, 2025 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 1 share at a price per share of $153.2237, with the Reporting Person's purchase of 1 share of common stock at a price per share of $148.262 on April 7, 2025. Dr. Curet paid to the Issuer $4.97, representing the full amount of the profit realized in connection with the short-swing transaction.